Specific glycosylation of α1-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV

Annals of the Rheumatic Diseases

Volumn 60, Issue 8, 2001, Pages 777-780

  Poland, D C W ^a   Drenth, J P H ^b   Rabinovitz, E ^c   Livneh, A ^c   Bijzet, J ^d   Van het Hof, B ^a   Van Dijk, W ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; C REACTIVE PROTEIN; CONCANAVALIN A; GLYCAN DERIVATIVE; OROSOMUCOID;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER; GENE; GENE MEFV; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOELECTROPHORESIS; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REMISSION;

ADOLESCENT; ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYTOSKELETAL PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GLYCOSYLATION; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; NORMAL DISTRIBUTION; OROSOMUCOID; PROTEINS; SERUM AMYLOID A PROTEIN; STATISTICS, NONPARAMETRIC;

EID: 0034943553     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.8.777     Document Type: Article

References (41)

1. Familial Mediterranean fever: High gene frequency among the non-Ashkenazic Jewish population in Israel
2. A candidate gene for familial Mediterranean fever
3. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever
4. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein pyrin
5. Familial Mediterranean fever
6. Familial Mediterranean fever: From the clinical syndrome to the cloning of the pyrin gene
7. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health
8. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever
9. The changing face of familial Mediterranean fever
10. Acute phase response and evolution of familial Mediterranean fever
11. Familial Mediterranean fever. A survey of 470 cases and review of the literature
12. Changes in the serum concentration and glycosylation of alpha1-acid glycoprotein and alpha1-protease inhibitor in severely burned patients: Relation to interleukin-6 levels
13. Microheterogeneity of alpha1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus
14. Effects of low-dose methotrexate therapy on the concentration and glycosylation of alpha1-acid glycoprotein in the serum of rheumatoid arthritis patients: A longitudinal study
15. Glycosylation of alpha1-acid glycoprotein (orosomucoid) in health and disease: Occurrence, regulation and possible functional implications
16. Inflammation-induced expression of sialyl Lewis x is not restricted to alpha1-acid glycoprotein but also occurs to a lesser extent on alpha1-antichymotrypsin and haptoglobin
17. Inflammation-induced expression of sialyl lewis X-containing glycan structures on alpha1-acid glycoprotein (orosomucoid) in human sera
18. Elevated serum-level and altered glycosylation of alpha 1-acid glycoprotein in hyperimmunoglobulinemia D and periodic fever syndrome: Evidence for persistent inflammation
19. Evidence for alpha1-acid glycoprotein populations of different pI values after concanavalin A affinity, chromatography. Study of their evolution during inflammation in man
20. Variations in the relative proportions of microheterogeneous forms of plasma glycoproteins in pregnancy and disease
21. Effects of severe burns on glycan microheterogeneity of four acute-phase proteins
22. Effects of monocytic products, recombinant interleukin-1 and recombinant interleukin-6 on the glycosylation of alpha1-acid glycoprotein: Studies with primary human hepatocyte cultures and rats
23. Increased affinity to concanavalin A and enhanced secretion of alpha1-acid glycoproteins by hepatocytes isolated from turpentine-treated rats
24. Acute-phase mediated change in glycosylation of rat alpha1-acid glycoprotein in transgenic mice
25. N-Glycosylation of serum proteins in disease and its investigation using lectins
26. Microheterogeneity forms of alpha1-acid glycoprotein as indicators of rheumatoid arthritis activity
27. Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum?
28. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: Evidence for chronic inflammation
29. Criteria for the diagnosis of familial Mediterranean fever
30. A single radial diffusion method for the immunological quantification of proteins
31. Monoclonal antibody based ELISA for human SAA
32. SAA versus CRP serum levels in different inflammatory conditions, studied by ELISA using polyclonal anti-AA and monoclonal anti-SAA antibodies
33. Crossed immunoaffinoelectrophoresis: An analytical method to predict the result of affinity chromatography
34. Leucocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever)
35. Activation of the cytokine network in familial Mediterranean fever
36. Diagnostic and treatment concerns in familial Mediterranean fever
37. Periodic fevers enter the era of molecular diagnosis
38. Hyperimmunoglobulinemia D and periodic fever. The clinical spectrum in a series of 50 patients
39. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome
40. Interleukine-6-type cytokine-induced changes in acute phase protein glycosylation
41. A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis